{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:31:11Z","timestamp":1792589471468,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.neulet.2023.137219","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T05:30:52Z","timestamp":1680586252000},"page":"137219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson\u2019s disease patients"],"prefix":"10.1016","volume":"804","author":[{"given":"Linrui","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5825-1927","authenticated-orcid":false,"given":"Jianjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanze","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dashuai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2023.137219_b0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1212\/WNL.0b013e31829c5c86","article-title":"Evolution of mild cognitive impairment in Parkinson disease","volume":"81","author":"Broeders","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2023.137219_b0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41531-019-0106-4","article-title":"Dementia in long-term Parkinson's disease patients: a multicentre retrospective study","volume":"6","author":"Szeto","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.neulet.2023.137219_b0015","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.2530630","article-title":"The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase","volume":"246","author":"Wilkinson","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.neulet.2023.137219_b0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.neulet.2023.137219_b0025","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2023.137219_b0030","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2023.137219_b0035","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2023.137219_b0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2023.137219_b0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.neulet.2023.137219_b0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2023.137219_b0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11136-004-0687-0","article-title":"Reliability and validity testing of a Chinese-translated version of the 39-item Parkinson's Disease Questionnaire (PDQ-39)","volume":"14","author":"Ma","year":"2005","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.neulet.2023.137219_b0060","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.neulet.2023.137219_b0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2023.137219_b0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.neulet.2023.137219_b0075","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2023.137219_b0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.27902","article-title":"Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta-analysis","volume":"35","author":"Baiano","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2023.137219_b0085","doi-asserted-by":"crossref","unstructured":"J. Cosgrove, J.E. Alty, S. Jamieson, Cognitive impairment in Parkinson's disease, Postgrad. Med. J. 91 (2015) 212-220. 10.1136\/postgradmedj-2015-133247.","DOI":"10.1136\/postgradmedj-2015-133247"},{"key":"10.1016\/j.neulet.2023.137219_b0090","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/1531-8257(200011)15:6<1119::AID-MDS1009>3.0.CO;2-0","article-title":"Estrogen use among nursing home residents with a diagnosis of Parkinson's disease","volume":"15","author":"Fernandez","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2023.137219_b0095","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jocn.2014.08.032","article-title":"Sex differences in cognition among Chinese people with Parkinson\u2019s disease","volume":"22","author":"Gao","year":"2015","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.neulet.2023.137219_b0100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.parkreldis.2014.01.011","article-title":"CSF alpha-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders","volume":"20","author":"Mondello","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neulet.2023.137219_b0105","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","article-title":"A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes","volume":"86","author":"Magdalinou","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2023.137219_b0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13024-020-00385-5","article-title":"Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease","volume":"15","author":"Ng","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neulet.2023.137219_b0115","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s11357-022-00576-6","article-title":"Elevated alpha-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease","volume":"44","author":"Lin","year":"2022","journal-title":"Geroscience"},{"key":"10.1016\/j.neulet.2023.137219_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577662","article-title":"Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease","volume":"358","author":"Zhu","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neulet.2023.137219_b0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow rate of cerebrospinal fluid (CSF)\u2013a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases","volume":"122","author":"Reiber","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2023.137219_b0130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jns.2006.05.011","article-title":"Cognitive decline correlates with neuropathological stage in Parkinson's disease","volume":"248","author":"Braak","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2023.137219_b0135","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","article-title":"Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment","volume":"11","author":"Svenningsson","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neulet.2023.137219_b0140","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2023.137219_b0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuint.2007.05.007","article-title":"The functions of UCH-L1 and its relation to neurodegenerative diseases","volume":"51","author":"Setsuie","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2023.137219_b0150","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"Alpha-Synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"Webb","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2023.137219_b0155","doi-asserted-by":"crossref","first-page":"e34713","DOI":"10.1371\/journal.pone.0034713","article-title":"Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy","volume":"7","author":"Cartier","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2023.137219_b0160","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2006.06.046","article-title":"Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory","volume":"126","author":"Gong","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2023.137219_b0165","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1460-9568.2008.06047.x","article-title":"Reduction in memory in passive avoidance learning, exploratory behaviour and synaptic plasticity in mice with a spontaneous deletion in the ubiquitin C-terminal hydrolase L1 gene","volume":"27","author":"Sakurai","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neulet.2023.137219_b0170","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1523\/JNEUROSCI.3148-16.2017","article-title":"Ubiquitin C-terminal hydrolase L1 (UCH-L1) promotes hippocampus-dependent memory via its deubiquitinating effect on TrkB","volume":"37","author":"Guo","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2023.137219_b0175","doi-asserted-by":"crossref","unstructured":"C.H. Lin, C.H. Li, K.C. Yang, F.J. Lin, C.C. Wu, J.J. Chieh, M.J. Chiu, Blood NfL: A biomarker for disease severity and progression in Parkinson disease, Neurology 93 (2019) e1104-e1111. 10.1212\/WNL.0000000000008088.","DOI":"10.1212\/WNL.0000000000008088"},{"key":"10.1016\/j.neulet.2023.137219_b0180","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3233\/JPD-212535","article-title":"Serum neurofilament dynamics predicts cognitive progression in de novo Parkinson's disease","volume":"11","author":"Ma","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neulet.2023.137219_b0185","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/mds.28779","article-title":"Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease","volume":"36","author":"Aamodt","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2023.137219_b0190","first-page":"53","article-title":"Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies","volume":"139","author":"Schmidt","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neulet.2023.137219_b0195","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/aws133","article-title":"Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease","volume":"135","author":"Chu","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2023.137219_b0200","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1212\/WNL.42.7.1315","article-title":"Epitope analysis of senile plaque components in the hippocampus of patients with Parkinson's disease","volume":"42","author":"Arai","year":"1992","journal-title":"Neurology"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023001763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023001763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:48:18Z","timestamp":1759625298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394023001763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":40,"alternative-id":["S0304394023001763"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137219","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson\u2019s disease patients","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"137219"}}